You just read:

Tresiba® (insulin degludec injection U-100) demonstrated significantly lower rates of overall, nocturnal and severe hypoglycaemia vs insulin glargine U-100

News provided by

Novo Nordisk

11 Jun, 2016, 16:00 BST